Pharma Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Charles University, Czech Republic
Reports from the Czech Republic, Germany and Denmark advance knowledge in obesity research
July 4th, 2006
Reports from the Czech Republic, Germany and Denmark highlight recent research in obesity. Study 1: Resistin physiology and pathophysiology may play important role in obesity-induced insulin resistance. According to a review from Czech Republic, "Resistin is a 12.5-kDa polypeptide hormone produced by adipocytes and immunocompetent cells. It was originally proposed as a link between obesity and insulin resistance/diabetes." "Later, studies revealed that substantial interspecies differences exist between the major sites of resistin production in rodents (adipocytes) and humans (immunocompetent cells). While in rodents resistin...
Source: Pharma Law Weekly (2006-07-04)
|
